Perioperative adjuvant therapy with short course of dupilumab with ESS for recurrent CRSwNP
Short-course adjuvant perioperative treatment with dupilumab is associated with improved long-term olfactory outcomes and persistent lowering of serum IgE.
Authors
- Sufia Jannat (ORCID: https://orcid.org/0000-0002-7477-678X)
- Thea Irani
- Audrey Pelletier (ORCID: https://orcid.org/0000-0003-3483-3329)
- Martin Desrosiers (ORCID: https://orcid.org/0000-0003-3774-2959)
- Léandra Mfuna Endam
- Emmanuel González (ORCID: https://orcid.org/0000-0002-5567-2125)
Institutions
- Centre Hospitalier de l’Université de Montréal (CA)
- McGill University (CA)
Publication Details
- Journal
- International Forum of Allergy & Rhinology
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1002/alr.23471
- Citations
- 9
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 5.22
Funders
- Sanofi
- Sanofi Genzyme